Airain Ltd’s Vertex Pharmaceuticals VRTX Stock Holding History

Airain Ltd’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$4.62M	Buy	+35,852	New	+$4.32M	0.2%	147
2016 Q2	–	Sell	-57,878	Closed	-$4.6M	–	917
2016 Q1	$4.6M	Buy	+57,878	New	+$5.24M	0.32%	81
2015 Q4	–	Sell	-8,472	Closed	-$882K	–	1075
2015 Q3	$882K	Sell	8,472 -1,246	-13%	-$160K	0.05%	357
2015 Q2	$1.2M	Buy	+9,718	New	+$1.22M	0.07%	305
2013 Q4	–	Sell	-8,776	Closed	-$665K	–	710
2013 Q3	$665K	Buy	+8,776	New	+$698K	0.12%	196

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Airain Ltd's VRTX Position: Q2 2017 in Review

Airain Ltd opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2017: 35,852 shares worth $4.62M. The stake represents 0.2% of the portfolio and ranks #147 among its holdings. This is a return to the name: Airain Ltd previously reported a position in VRTX as recently as Q1 2016.

Airain Ltd first reported a position in VRTX in Q3 2013 and has held it in 5 quarters since. 582 funds tracked by Wall St. Rank hold VRTX as of Q2 2017.

Airain Ltd held 35,852 shares of Vertex Pharmaceuticals worth $4.62M as of Q2 2017.
Vertex Pharmaceuticals was a new Airain Ltd position in Q2 2017.
Vertex Pharmaceuticals made up 0.2% of Airain Ltd's portfolio in Q2 2017, its #147 holding.
Airain Ltd first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 5 quarters since.
582 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.